1110 Stock Overview
An investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Kingworld Medicines Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.46 |
| 52 Week High | HK$0.67 |
| 52 Week Low | HK$0.40 |
| Beta | 0.77 |
| 1 Month Change | 5.81% |
| 3 Month Change | -12.50% |
| 1 Year Change | -31.06% |
| 3 Year Change | -39.33% |
| 5 Year Change | -47.70% |
| Change since IPO | -77.80% |
Recent News & Updates
The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence
Nov 13
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04Recent updates
The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence
Nov 13Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338
May 31Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely
May 22Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22Shareholder Returns
| 1110 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -0.5% |
| 1Y | -31.1% | -17.8% | 19.9% |
Return vs Industry: 1110 underperformed the Hong Kong Healthcare industry which returned -17.8% over the past year.
Return vs Market: 1110 underperformed the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 1110 volatility | |
|---|---|
| 1110 Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 8.3% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 1110 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1110's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 927 | Li Sheng Zhao | www.kingworld.com.cn |
Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceutical, healthcare, general foodstuffs, and medical products.
Kingworld Medicines Group Limited Fundamentals Summary
| 1110 fundamental statistics | |
|---|---|
| Market cap | HK$269.86m |
| Earnings (TTM) | HK$33.13m |
| Revenue (TTM) | HK$1.12b |
8.1x
P/E Ratio0.2x
P/S RatioIs 1110 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1110 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.05b |
| Cost of Revenue | CN¥788.49m |
| Gross Profit | CN¥263.24m |
| Other Expenses | CN¥232.15m |
| Earnings | CN¥31.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.052 |
| Gross Margin | 25.03% |
| Net Profit Margin | 2.96% |
| Debt/Equity Ratio | 49.6% |
How did 1110 perform over the long term?
See historical performance and comparisonDividends
7.1%
Current Dividend Yield58%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 08:46 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kingworld Medicines Group Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lok Kwan Chiu | GF Securities (Hong Kong) Brokerage Limited |
| Feng Qiang Sun | Guotai Junan International Holdings Limited |
| T. J. Hsu | KGI Securities Co. Ltd. |